In Treatment of Abdominal pain Udrota P 80mg/325mg Tablet effectively relieves sudden muscle spasms or contractions in the stomach and intestine (gut), thereby relaxing the muscles and improving movement of food. It also blocks chemical messengers in the brain that are responsible for pain sensation. This helps to treat abdominal pain (or stomach pain) as well as cramps, bloating and discomfort. Take Udrota P 80mg/325mg Tablet as prescribed by the doctor. Eventually, it will help you to go about your daily activities more easily and have a better, more active, quality of life.
It is unsafe to consume alcohol with Udrota P 80mg/325mg Tablet.
Udrota P 80mg/325mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Udrota P 80mg/325mg Tablet during breastfeeding is not available. Please consult your doctor.
Udrota P 80mg/325mg Tablet may cause side effects which could affect your ability to drive. As Udrota P 80mg/325mg Tablet may cause vertigo.
Udrota P 80mg/325mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Udrota P 80mg/325mg Tablet may be needed. Please consult your doctor. Use of Udrota P 80mg/325mg Tablet is not recommended in patients with severe kidney disease.
Udrota P 80mg/325mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Udrota P 80mg/325mg Tablet may be needed. Please consult your doctor.
If you miss a dose of Udrota P 80mg/325mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More